Abstract 2022-RA-1356-ESGO Table 1

Characteristic of patients with BM according to the BRCA status

All patients with BM94 (100) Patients with known BRCA status66 (100) BRCAwt patients45 (100) BRCAm patients 21 (100) P value BRCAm vs BRCAwt
AGE at OC diagnosis Years, mean (SD)58.12 (10.68) 58.16 (10.67) 60.8 (10.48) 52.52 (8.91) 0.001
AGE at BM diagnosis Years, mean (SD) 60.94 (10.26) 61.21 (10.26) 63.62 (9.94) 56.04 (9.16) 0.002
TIME OC-BM diagnosis Months, mean (SD) 31.87 (24.27) 34.39 (27) 33.00 (28) 37.38 (24.87) 0.27
SITE OF BM No (%) Cerebellum 15 (16) 10 (15.2) 6 (13.3) 4 (19.0) 0.59
Cerebrum 46 (48.9) 35 (53.0) 23 (51.1) 12 (57.1)
Mixed (+/- leptomeninges) 33 (35.1) 21 (31.8) 16 (35.6) 5 (23.8)
NUMBER OF BM No (%) Single 38 (40.4) 26 (39.4) 17 (37.8) 9 (42.9) 0.448
Multiple 56 (59.6) 40 (60.6) 28 (62.2) 12 (57.1)
NEUROLOGICAL SYMPTOMS No (%) YES 50 (53.2) 33 (50) 25 (55.6) 8 (38.1) 0.145
NO 44 (46.8) 33 (50) 20 (44.4) 13 (61.9)
CNS DISEASE ONLY No (%) YES 35 (37.2) 23 (34.8) 16 (35.6) 7 (33.3) 0.544
NO 59 (62.8) 43 (65.2) 29 (64.4) 14 (66.7)
TYPE OF TREATMENT No (%) Radiotherapy only 15 (16) 9 (13.6) 7 (15.6) 2 (9.5) 0.33
Chemotherapy only 2 (2.1) 1 (1.5) 0 (0) 1 (4.8)
Surgery only 3 (3.2) 3 (4.5) 2 (4.4) 1 (4.8)
Chemotherapy + Radiotherapy or Surgery 43 (45.7) 30 (45.5) 18 (40) 12 (57.1)
Radiotherapy + Surgery 9 (9.6) 7 (10.6) 6 (13.3) 1 (4.8)
Chemotherapy + Radiotherapy + Surgery 17 (18.1) 11 (16.7) 7 (15.6) 4 (19)
None 5 (5.3) 5 (7.6) 5 (11.1) 0 (0)